Your browser doesn't support javascript.
loading
A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer.
Takahashi, Shunji; Takekuma, Munetaka; Tamura, Kenji; Takehara, Kazuhiro; Nomura, Hiroyuki; Ono, Makiko; Yunokawa, Mayu; Aoki, Daisuke.
Afiliação
  • Takahashi S; Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-0063, Japan.
  • Takekuma M; Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Tamura K; National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Takehara K; Shimane University Hospital, 89-1 Enya-cho, Izumo-shi, Shimane, 693-8501, Japan.
  • Nomura H; National Hospital Organization Shikoku Cancer Center, 160 Kou, Minamiumemotomachi, Matsuyama-shi, Ehime, 791-0245, Japan.
  • Ono M; Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
  • Yunokawa M; Fujita Health University, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
  • Aoki D; Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-0063, Japan.
Int J Clin Oncol ; 26(10): 1977-1985, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34189636

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article